Statistics
Publications
6
Citations
416
H-Index
6
Active since
2015
Katherine Labella is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and medicine.
Publications per year
2015–2021
6
6
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Ji Li, Peter S. Choi, Christine L. Chaffer et al. · eLife · 2018 · 125 citations · Full text
Development of Selective Covalent Janus Kinase 3 Inhibitors
Li Tan, Koshi Akahane, Randall McNally et al. · Journal of Medicinal Chemistry · 2015 · 115 citations · Full text
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition
Andrew L. Hong, Yuen‐Yi Tseng, Jeremiah A. Wala et al. · eLife · 2019 · 53 citations · Full text
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
Chao Dai, Jonathan Rennhack, Taylor E. Arnoff et al. · Cell Reports · 2021 · 47 citations · Full text
Medicine, Cancer Biology, Oncology +17
Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6
Atish D. Choudhury, Anna C. Schinzel, Maura B. Cotter et al. · Cancer Research · 2016 · 42 citations · Full text
1–5 of 6